New Peptide Stapling Methods From Mushroom Toxin Chemistry Enable Sub-Nanomolar Drug Candidates

Tryptathionine and 2,2'-bis-indole staples — natural motifs from amatoxins and staurosporine — were efficiently applied to staple peptide drugs, yielding sub-nanomolar binding affinity for melanocortin receptors.

Todorovic, Mihajlo et al.·Chemistry (Weinheim an der Bergstrasse·2024·Preliminary Evidencein vitro
RPEP-09390In vitroPreliminary Evidence2024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in vitro
Evidence
Preliminary Evidence
Sample
N=N/A (chemistry)
Participants
Synthetic peptide chemistry (melanotan-II as model peptide)

What This Study Found

Both tryptathionine and 2,2'-bis-indole stapling of α-MSH produced nanomolar Ki values, with one stapled variant achieving sub-nanomolar affinity for melanocortin receptors.

Key Numbers

Two new staple types developed: tryptathionine (from amatoxins/phallotoxins) and 2,2'-bis-indole (from staurosporine). Applied to melanotan-II.

How They Did This

Chemical synthesis using 5-hydroxypyrroloindoline condensation with cysteine-thiol or tryptophan-indole, applied to α-MSH as a model peptide, with binding affinity measured against melanocortin receptors.

Why This Research Matters

Peptide stapling is key to making peptide drugs more stable and cell-penetrating. These new staple types from natural product chemistry expand the peptide drug designer's toolkit and could enable development of more potent, stable therapeutic peptides.

The Bigger Picture

As peptides become increasingly important as drugs, finding new ways to stabilize their three-dimensional structures is crucial. Drawing inspiration from toxic natural products to create drug-like stapled peptides represents a creative convergence of natural product chemistry and drug design.

What This Study Doesn't Tell Us

Demonstrated on only one model peptide (α-MSH); binding affinity measured but not cellular activity or in vivo efficacy; metabolic stability of stapled peptides not assessed; limited exploration of staple position effects; no comparison to existing stapling methods.

Questions This Raises

  • ?Do these natural product staples improve peptide cell permeability and metabolic stability?
  • ?Can these stapling methods be applied to therapeutic peptides targeting disease-relevant receptors?
  • ?How does the conformational constraint compare to established staple types like hydrocarbon staples?

Trust & Context

Key Stat:
Sub-nanomolar Ki binding affinity achieved with natural product-inspired peptide staple
Evidence Grade:
Preliminary proof-of-concept for new peptide chemistry. Demonstrates feasibility and high binding affinity but lacks biological validation and drug-like property assessment.
Study Age:
Published in 2024, contributing novel peptide stapling methods to the growing field of constrained peptide therapeutics.
Original Title:
5-Hydroxypyrroloindoline Affords Tryptathionine and 2,2'-bis-Indole Peptide Staples: Application to Melanotan-II.
Published In:
Chemistry (Weinheim an der Bergstrasse, Germany), 30(19), e202304270 (2024)
Database ID:
RPEP-09390

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What is peptide stapling?

It's a technique to lock a peptide drug into a specific 3D shape by adding a chemical bridge (staple) between two points. This makes the peptide more stable, more likely to enter cells, and often more potent at binding its target.

Why use mushroom toxin chemistry for drug design?

The deadly amatoxins in mushrooms are incredibly potent precisely because their peptide structure is rigidly stapled. By borrowing these natural stapling motifs, chemists can create similarly rigid and potent — but non-toxic — therapeutic peptides.

Read More on RethinkPeptides

Cite This Study

RPEP-09390·https://rethinkpeptides.com/research/RPEP-09390

APA

Todorovic, Mihajlo; Blanc, Antoine; Wang, Zhou; Lozada, Jerome; Froelich, Juliette; Zeisler, Jutta; Zhang, Chengcheng; Merkens, Helen; Benard, Francois; Perrin, David M. (2024). 5-Hydroxypyrroloindoline Affords Tryptathionine and 2,2'-bis-Indole Peptide Staples: Application to Melanotan-II.. Chemistry (Weinheim an der Bergstrasse, Germany), 30(19), e202304270. https://doi.org/10.1002/chem.202304270

MLA

Todorovic, Mihajlo, et al. "5-Hydroxypyrroloindoline Affords Tryptathionine and 2,2'-bis-Indole Peptide Staples: Application to Melanotan-II.." Chemistry (Weinheim an der Bergstrasse, 2024. https://doi.org/10.1002/chem.202304270

RethinkPeptides

RethinkPeptides Research Database. "5-Hydroxypyrroloindoline Affords Tryptathionine and 2,2'-bis..." RPEP-09390. Retrieved from https://rethinkpeptides.com/research/todorovic-2024-5hydroxypyrroloindoline-affords-tryptathionine-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.